|
Market Closed -
NYSE
16:00:02 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 135.90 USD | +3.35% |
|
+9.52% | +28.04% |
| 10-30 | UBS Adjusts Encompass Health Price Target to $165 From $155, Maintains Buy Rating | MT |
| 10-30 | Truist Securities Adjusts Encompass Health Price Target to $156 From $150, Maintains Buy Rating | MT |
| Market Cap | 13.41B 12.01B 11.04B 10.01B 18.71B 1,273B 19.06B 132B 52.87B 670B 50.32B 49.25B 2,112B | P/E 2026 * |
20.8x | P/E 2027 * | 19.6x |
|---|---|---|---|---|---|
| Enterprise Value | 15.99B 14.32B 13.18B 11.94B 22.31B 1,519B 22.73B 157B 63.07B 799B 60.02B 58.74B 2,519B | EV / Sales 2026 * |
2.47x | EV / Sales 2027 * | 2.27x |
| Free-Float |
85.27% | Yield 2026 * |
0.57% | Yield 2027 * | 0.6% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| EHC | Delayed | |
CBOE
| EHC | Real-time | |
|
Mexican S.E.
| EHC * | End-of-day quote | |
|
Börse Stuttgart
| HSOA | Delayed | |
|
Boerse Muenchen
| HSOA | Real-time | |
|
Deutsche Boerse AG
| HSOA | Delayed | |
|
Tradegate
| HSOA | Real-time | |
|
Xetra
| HSOA | Delayed |
Last Transcript: Encompass Health Corporation
| 1 day | +3.35% | ||
| 1 week | +9.52% | ||
| 1 month | +11.86% | ||
| 3 months | +22.36% | ||
| 6 months | +35.90% | ||
| Current year | +28.04% |
| 1 week | 120.95 |  | 137.27 |
| 1 month | 118.39 | | 137.27 |
| Current year | 92.77 | | 137.27 |
| 1 year | 92.77 | | 137.27 |
| 3 years | 62.58 | | 137.27 |
| 5 years | 44.33 | | 137.27 |
| 10 years | 36.97 | | 137.27 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Tarr
CEO | Chief Executive Officer | 64 | 2016-12-28 |
Douglas Coltharp
DFI | Director of Finance/CFO | 64 | 2010-05-05 |
Patrick Tuer
COO | Chief Operating Officer | 42 | 2025-04-23 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Tarr
BRD | Director/Board Member | 64 | 2016-12-28 |
Joan Herman
BRD | Director/Board Member | 72 | 2013-01-24 |
Leslye Katz
BRD | Director/Board Member | 71 | 2013-01-24 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/31/26 | Exercice | General Counsel | 14,574 | 0.0148% | ||
| 8/31/26 | Sell | Controller/Auditor | -5,211 | 0.0053% | ||
| 8/10/26 | Sell | Chief Financial Officer | -18,869 | 0.0190% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.35% | +9.52% | +19.37% | +117.23% | 13.41B | |
| -0.09% | -3.44% | +15.48% | +30.78% | 115B | |
| -1.02% | +0.89% | +2.94% | +109.25% | 98.85B | |
| -4.98% | +2.56% | +108.26% | +949.66% | 59.72B | |
| +1.44% | +1.95% | -6.04% | +93.89% | 30.06B | |
| -1.84% | +9.86% | +42.30% | +80.94% | 29.34B | |
| -0.43% | +4.11% | +43.12% | +93.56% | 27.71B | |
| +0.99% | +1.79% | +32.33% | +408.85% | 21.75B | |
| -1.58% | +2.35% | -18.66% | -15.18% | 20.66B | |
| -.--% | -0.63% | -4.85% | +30.83% | 17.09B | |
| Average | -0.42% | +3.21% | +23.43% | +189.98% | 43.4B | |
| Weighted average by Cap. | -0.92% | +1.33% | +26.02% | +206.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.48B 5.8B 5.33B 4.83B 9.03B 615B 9.2B 63.61B 25.54B 323B 24.3B 23.78B 1,020B | 7.02B 6.29B 5.78B 5.24B 9.79B 666B 9.98B 68.94B 27.68B 351B 26.34B 25.78B 1,105B |
| Net income | 639M 573M 527M 477M 892M 60.71B 909M 6.28B 2.52B 31.94B 2.4B 2.35B 101B | 692M 620M 570M 517M 966M 65.73B 984M 6.8B 2.73B 34.57B 2.6B 2.54B 109B |
| Net Debt | 2.59B 2.32B 2.13B 1.93B 3.61B 246B 3.68B 25.41B 10.2B 129B 9.71B 9.5B 407B | 2.53B 2.27B 2.09B 1.89B 3.53B 240B 3.6B 24.87B 9.98B 126B 9.5B 9.3B 399B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-30 | US$135.90 | +3.35% | 1,797,654 |
| 26-10-29 | US$131.49 | +7.70% | 2,197,540 |
| 26-10-28 | US$122.09 | +0.46% | 1,007,907 |
| 26-10-27 | US$121.53 | -2.07% | 727,116 |
| 26-10-26 | US$124.10 | +0.01% | 843,864 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EHC Stock
Select your edition
All financial news and data tailored to specific country editions
